SR 141716A enhances spatial memory as assessed in a radial-arm maze task in rats

被引:145
作者
Lichtman, AH [1 ]
机构
[1] Virginia Commonwealth Univ, Med Coll Virginia, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA
关键词
radial-arm maze; SR141716A; cannabinoid; working memory;
D O I
10.1016/S0014-2999(00)00615-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A tonically active endogenous cannabinoid system has been proposed to modulate learning and memory. The purpose of the present study was to determine whether administration of the cannabinoid CB1 receptor antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,3-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR 141716A) would enhance memory as assessed in an eight-arm radial maze task. Because the high degree of choice accuracy in the standard radial-arm maze procedure precludes the possibility of detecting memory enhancement, the difficulty of the task was increased by imposing a delay of varying durations between a two-phase procedure consisting of acquisition and test phases. Significantly fewer errors were committed during the test phase following an injection of SR 141716A than the vehicle treatment. These results provide additional evidence supporting the hypothesis that endogenous cannabinoid systems play a role in memory processes. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:175 / 179
页数:5
相关论文
共 24 条
  • [1] Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors
    Arnone, M
    Maruani, J
    Chaperon, F
    Thiebot, MH
    Poncelet, M
    Soubrie, P
    LeFur, G
    [J]. PSYCHOPHARMACOLOGY, 1997, 132 (01) : 104 - 106
  • [2] Bohme GA, 2000, NEUROSCIENCE, V95, P5
  • [3] A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1 - Evidence for a new model of receptor/ligand interactions
    Bouaboula, M
    Perrachon, S
    Milligan, L
    Canat, X
    RinaldiCarmona, M
    Portier, M
    Barth, F
    Calandra, B
    Pecceu, F
    Lupker, J
    Maffrand, JP
    LeFur, G
    Casellas, P
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (35) : 22330 - 22339
  • [4] Brodkin J, 1997, J PHARMACOL EXP THER, V282, P1526
  • [5] Appetite suppression and weight loss after the cannabinoid antagonist SR141716
    Colombo, G
    Agabio, R
    Diaz, G
    Lobina, C
    Reali, R
    Gessa, GL
    [J]. LIFE SCIENCES, 1998, 63 (08) : PL113 - PL117
  • [6] Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat
    Felder, CC
    Nielsen, A
    Briley, EM
    Palkovits, M
    Priller, J
    Axelrod, J
    Nguyen, DN
    Richardson, JM
    Riggin, RM
    Koppel, GA
    Paul, SM
    Becker, GW
    [J]. FEBS LETTERS, 1996, 393 (2-3) : 231 - 235
  • [7] Learning impairment produced in rats by the cannabinoid agonist HU 210 in a water-maze task
    Ferrari, F
    Ottani, A
    Vivoli, R
    Giuliani, D
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1999, 64 (03) : 555 - 561
  • [8] Role of cannabinoid receptors in memory storage
    Hampson, RE
    Deadwyler, SA
    [J]. NEUROBIOLOGY OF DISEASE, 1998, 5 (06) : 474 - 482
  • [9] CHARACTERIZATION AND LOCALIZATION OF CANNABINOID RECEPTORS IN RAT-BRAIN - A QUANTITATIVE INVITRO AUTORADIOGRAPHIC STUDY
    HERKENHAM, M
    LYNN, AB
    JOHNSON, MR
    MELVIN, LS
    DECOSTA, BR
    RICE, KC
    [J]. JOURNAL OF NEUROSCIENCE, 1991, 11 (02) : 563 - 583
  • [10] HEYSER CJ, 1993, J PHARMACOL EXP THER, V264, P294